NRx Pharmaceuticals (NRXP) CEO to Provide Business Update on January 10th

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage, biopharmaceutical company, today announced its Chairman of the Board and Chief Executive Officer, Prof Jonathan Javitt, MD, MPH, will be presenting updates to the Company’s business at the H.C. Wainwright BioConnect Virtual Conference.

Details of the presentation can be found below:

Date: Monday, January 10, 2022

Time: 7:00 AM EST

Link to Presentation: https://journey.ct.events/view/1464b340-bd79-4a96-ae16-572a470d569b

You May Also Be Interested In

• Huang Calls AI 'the Great Equalizer' During G20 Event
• Yatra board rejects Magna Holdings' $1.10-per-share tender offer
• Etsy to join Goldman Sachs tech conference on Sept. 9